Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

QLT Inc (NASDAQ:QLTI)

3.80
Delayed Data
As of Aug 04
 +0.02 / +0.53%
Today’s Change
3.22
Today|||52-Week Range
6.68
-5.24%
Year-to-Date

Today’s Trading

Previous close3.78
Today’s open3.71
Day’s range3.71 - 3.81
Volume122,932
Average volume (3 months)345,192
Market cap$199.2M
Dividend yield103.10%
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)+83.67%
Earnings growth (this year)-525.00%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.23

Competitors

 Today’s
change
Today’s
% change
RKDAArcadia Biosciences ...-0.07-1.60%
--Mologen AG-1.62-12.62%
ENZEnzo Biochem Inc+0.03+1.01%
PRTOProteon Therapeutics...+0.50+3.07%
Data as of 08/04/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$0.00
Annual profit (last year)-$4.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Independent Director
Geoffrey F. Cox
Chief Financial Officer &
Vice President-Finance
Glen Ibbott
Corporate headquarters
Vancouver, British Columbia

Forecasts